Carotid stenoses of ≥50% account for about 15-20% of
strokes. Their degree may be moderate (50-69%) or severe (70-99%). Current diagnostic methods include ultrasound, MR- or CT-angiography.
Stenosis severity, irregular plaque surface, and presence of microembolic signals detected by transcranial Doppler predict the early recurrence risk, which may be as high as 20%. Initial
therapy comprises antiplatelets and
statins. Benefit of revascularization is greater in men, in older patients, and in severe
stenosis; patients with moderate
stenoses may also profit particularly if the plaque has an irregular aspect. An intervention should be performed within <2 weeks. In large randomized studies comparing
endarterectomy and stenting, endovascular
therapy was associated with a higher risk of periprocedural
stroke, yet in some studies, with a lower risk of
myocardial infarction and of
cranial neuropathy. These trials support
endarterectomy as the first choice treatment. Risk factors for each of the two
therapies have been indentified:
coronary artery disease, neck radiation, contralateral laryngeal nerve
palsy for
endarterectomy, and, elderly patients (>70 years), arch vessel tortuosity and plaques with low echogenicity on ultrasound for carotid stenting. Lastly, in direct comparisons, a contralateral occlusion increases the risk of periprocedural complications in both types of treatment.